Artia Global Partners’s 89bio ETNB Stock Holding History

Artia Global Partners’s Portfolio ETNB Stock Details ETNB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-465,465	Closed	-$7.19M	–	33
2023 Q3	$7.19M	Hold	465,465	–	–	2.99%	9
2023 Q2	$8.82M	Buy	+465,465	New	+$8.17M	3.04%	13

Other funds holding ETNB

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

SCM

Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return

Artia Global Partners's ETNB Position: Q4 2023 in Review

Artia Global Partners sold out of 89bio (ETNB) in Q4 2023, closing a stake of 465,465 shares — an estimated $7.19M sold.

Artia Global Partners first reported a position in ETNB in Q2 2023 and held it in 2 quarters. The position peaked at $8.82M in Q2 2023. 153 funds tracked by Wall St. Rank hold ETNB as of Q4 2023.

Artia Global Partners reported no remaining 89bio position as of Q4 2023 after selling out during the quarter.
Artia Global Partners sold 465,465 89bio shares in Q4 2023, an estimated $7.19M.
Artia Global Partners first reported a position in 89bio in Q2 2023 and held it in 2 quarters.
Artia Global Partners's 89bio position peaked at $8.82M in Q2 2023.
153 funds tracked by Wall St. Rank held 89bio as of Q4 2023.

Based on Artia Global Partners's 13F filing for Q4 2023, filed 14 Feb 2024.